CASE Op-Ed in DC Journal: Consumer Health and Safety Are on the Line. Where Is the FDA?
May 23, 2023 In an ever-changing consumer economy, one enduring timeworn constant is people today remain susceptible to misleading...
CASE Sends Letter to FDA, FTC RE: False Claims of DAXXIFY Skin Treatment
January 18, 2023 (Alexandria, Virginia) — Today Consumer Action for a Strong Economy (CASE) sent a letter to high-level...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/